CORRECTION: Clovis Oncology Will Not Be Presenting Initial Phase 1b/2 Data For Lucitanib With Opdivo At ASCO This Weekend; Earlier Headline Incorrectly Suggested This Event Would Be Upcoming This Week
Benzinga Newsdesk